Financhill
Back

Immunome, Inc. Stock Predictions

Immunome, Inc. Stock Forecast

  • Over the next 52 weeks, Immunome, Inc. has on average historically risen by 48.4% based on the past 5 years of stock performance.
  • Immunome, Inc. has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
  • Is Immunome, Inc. Stock Undervalued?
    The current Immunome, Inc. [IMNM] share price is $24.75. The Score for IMNM is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • IMNM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Immunome, Inc. Stock Go Up Next Year?

  • Over the next 52 weeks, Immunome, Inc. has on average historically risen by 48.4% based on the past 5 years of stock performance.

Immunome, Inc. Stock Rating

Buy
60
Immunome, Inc. (IMNM) is a Buy

Is Immunome, Inc. overpriced?

  • Immunome, Inc. has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%

Immunome, Inc. Stock Price History

Is IMNM stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IMNM is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
immunome.com

52-Week Data

52-Week High:
26.63
52-Week Low:
5.15

Prediction Charts

Market Cap:
2.3B
Price in USD:
24.75
Volume:
1.2M
Beta:
1.94

Technical Analysis

SMA50:
20.67
SMA100:
16.97
SMA200:
13.05
52-Wk Change:
167.86%

Stock Predictions

  • Is Immunome, Inc. stock public?
    Yes, Immunome, Inc. is a publicly traded company.
  • What is the Immunome, Inc. stock quote today?
    The Immunome, Inc. stock price is 24.75 USD today.
  • How to buy Immunome, Inc. stock online?
    You can buy Immunome, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jan-8 19.55 20.45 20.80 19.42
Jan-9 20.92 21.07 22.01 20.73
Jan-12 20.97 20.57 21.21 19.60
Jan-13 20.42 20.14 20.44 19.67
Jan-14 20.16 20.76 21.16 20.06
Jan-15 20.61 22.85 22.91 20.05
Jan-16 22.86 22.41 23.35 22.24
Jan-20 21.56 23.88 24.02 21.39
Jan-21 23.89 24.87 24.92 23.51
Jan-22 24.84 25.82 25.85 24.50
Jan-23 25.63 25.87 26.36 24.85
Jan-26 25.53 25.43 26.63 24.82
Jan-27 25.45 25.70 25.97 24.91
Jan-28 25.66 24.75 25.90 24.65

Immunome, Inc. Earnings

Immunome, Inc. Earnings Report: Per Share Immunome, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Immunome, Inc. Forecast Revenue Growth

Immunome, Inc. Stock Analysis: Historical quarterly revenues per share for Immunome, Inc. and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.26 per share, and an increase next year of $0.36 per share.

* Immunome, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.